Fluorine-18 P16 129
Alternative Names: [18F]AV-45; [18F]D3FSP; [18F]P16-129; F-18 P16-129Latest Information Update: 02 Oct 2021
At a glance
- Originator Five Eleven Pharma
- Class Aniline compounds; Diagnostic agents; Imaging agents; Pyridines; Radiopharmaceutical diagnostics; Small molecules
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 28 Jun 2021 No recent reports of development identified for phase-I development in Alzheimer's-disease(Diagnosis) in USA (IV, Injection)
- 02 Nov 2019 Five Eleven Pharma completes phase I trial in Alzheimer's disease (Diagnosis) in USA (IV) in November 2019 (NCT03902548)
- 01 Jan 2019 Pharmacodynamics data from preclinical studies in Alzheimer's disease released by Five Eleven Pharma